How to read: Every bubble is one Indian letrozole exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Letrozole report covers
KEY TAKEAWAYEvery figure in this report is grounded in real commercial letrozole trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian letrozole suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Letrozole India trade report
P
Product scope
Letrozole
All variants merged — branded and generic formulations of letrozole
T
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
S
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
G
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
C
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
R
Shipments analysed
264
Every commercial letrozole trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY2025-Q4 followed a v-curve: Oct $911.9K, Nov $738.6K, Dec $1.6M. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$911.9K
Oct USD
67 shipments
2
$738.6K
Nov USD
-19.0% MoM
3
$1.6M
Dec USD
+114.3% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 19.0% in USD but shipment count kept climbing.
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $912K, making it the middle month by value.
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: CIPLA LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import letrozole from India, how much they buy, and who supplies each market
KEY TAKEAWAYThailand absorbs 18.2% of India’s 2025-Q4 letrozole trade ($587.5K). Beyond the top 10 destinations, 47 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 18 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 47 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much letrozole India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$1.4M
43.5% of trade
13 countries · 97 shipments
Europe
$1.1M
34.4% of trade
8 countries · 90 shipments
Americas
$579K
17.9% of trade
9 countries · 21 shipments
Africa
$78K
2.4% of trade
18 countries · 54 shipments
Oceania
$58K
1.8% of trade
1 countries · 2 shipments
Fig 4.1 Thailand is the #1 corridor ($588K) — 30 flow arcs from India radiate across 5 continents.
How to read: The world map shows every country colored by how much Indian letrozole it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
#
Destination
Total USD
Ships
#1 Indian supplier
USD
#2 Indian supplier
USD
#3 Indian supplier
USD
1
Thailand
$588K
3
CIPLA LTD
$588K
—
—
—
—
2
Malta
$354K
31
EUGIA PHARMA SPECIALITIES LTD
$354K
INTAS PHARMACEUTICALS LTD
$262
—
—
3
Myanmar
$273K
5
SUN PHARMACEUTICAL INDUSTRIES LTD
$250K
GLOBELA PHARMA PVT LTD
$13K
SRS PHARMACEUTICALS PVT LTD
$9K
4
Canada
$236K
5
CIPLA LTD
$210K
INTAS PHARMACEUTICALS LTD
$26K
—
—
5
United Kingdom
$222K
15
INTAS PHARMACEUTICALS LTD
$97K
CIPLA LTD
$50K
SAKAR HEALTHCARE LTD
$42K
6
United States
$219K
5
EUGIA PHARMA SPECIALITIES LTD
$139K
INTAS PHARMACEUTICALS LTD
$80K
—
—
7
Philippines
$208K
7
SUN PHARMACEUTICAL INDUSTRIES LTD
$162K
INTAS PHARMACEUTICALS LTD
$37K
MALLESHWAR SPECIALITIES
$5K
8
Greece
$188K
14
INTAS PHARMACEUTICALS LTD
$188K
—
—
—
—
9
Netherlands
$175K
20
INTAS PHARMACEUTICALS LTD
$175K
—
—
—
—
10
Sri Lanka
$162K
1
SUN PHARMACEUTICAL INDUSTRIES LTD
$162K
—
—
—
—
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 43.5% of USD — but Thailand is the single largest market.
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
18.2%
#1 country share
Thailand alone
51.7%
Top 5 share
5 of 49 countries
94.8%
Top 15 share
Long tail of 34 countries = 5.2%
HHI 845
Destination HHI
Competitive spread
49
Countries served
Global pharma reach from India
18
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
68 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAYCIPLA LTD ($905.5K, 28.0% share) and SUN PHARMACEUTICAL INDUSTRIES LTD ($848.0K) together control 54.2% of India’s 2025-Q4 letrozole trade. The top 5 suppliers hold 94.6%. 68 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian letrozole suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 CIPLA LTD leads by $57K over SUN PHARMACEUTICAL INDUSTRIES LTD — top 20 Indian exporters ranked by trade value
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MALLESHWAR SPECIALITIES is #16 by value but #9 by volume.
Fig 5.2 INTAS PHARMACEUTICALS LTD also leads by shipment count (72) but ranking shifts for volume-heavy players
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MALLESHWAR SPECIALITIES moves from #9 by volume to #16 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 68 letrozole suppliers split into strategic segments
KEY TAKEAWAY17 suppliers (25%) generate 99.1% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 CIPLA LTD and SUN PHARMACEUTICAL INDUSTRIES LTD sit in the leaders zone — high volume AND high value.
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.1% of USD — classic concentration.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 5 importers per destination.
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
72 importers across 49 countries — who is buying Indian letrozole and how much
KEY TAKEAWAYThe demand side is dramatically more fragmented than supply: the top 25 importers together hold only 85.0% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian letrozole. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 THE GOVERNMENT PHARMACEUTICAL ORGAN is the #1 importer at $588K (18.2%) — top 25 by trade value
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian letrozole prices vary by supplier, country and dosage form
KEY TAKEAWAYLetrozole prices span 62145× ($0.0004 → $22.91). The coefficient of variation is 2.50. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. CIPLA LTDSourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. SUN PHARMACEUTICAL INDUSTRIESSourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAYExtreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
RUHAN IMPEX
United Arab Emirates
Tablet
1
$30.23
$30.23
Specialty / small-batch
Nov 2025
RUHAN IMPEX
United Arab Emirates
Tablet
1
$24.37
$24.37
Specialty / small-batch
Dec 2025
RUHAN IMPEX
United Arab Emirates
Tablet
4
$91.63
$22.91
Specialty / small-batch
Nov 2025
RUHAN IMPEX
United Arab Emirates
Tablet
18
$379.17
$21.06
Specialty / small-batch
Nov 2025
RUHAN IMPEX
United Arab Emirates
Tablet
18
$379.17
$21.06
Specialty / small-batch
Dec 2025
RUHAN IMPEX
United Arab Emirates
Tablet
3
$59.32
$19.77
Specialty / small-batch
Nov 2025
RUHAN IMPEX
United Arab Emirates
Tablet
7
$137.03
$19.58
Specialty / small-batch
Nov 2025
RUHAN IMPEX
United Arab Emirates
Tablet
9
$167.48
$18.61
Specialty / small-batch
Dec 2025
RUHAN IMPEX
United Arab Emirates
Tablet
1
$18.47
$18.47
Specialty / small-batch
Nov 2025
RUHAN IMPEX
United Arab Emirates
Tablet
2
$35.77
$17.89
Specialty / small-batch
↓ TOP 10 LOWEST USD/UNIT
Date
Exporter
Country
Dosage
Qty
USD
$/unit
Why
Dec 2025
SCOTT EDIL PHARM…
DR Congo
Tablet
15K
$25.16
$0.0017
Bulk generic tablet
Dec 2025
NEXTWELL PHARMAC…
Somalia
Tablet
500
$1.21
$0.0024
Bulk generic tablet
Dec 2025
NEXTWELL PHARMAC…
Somalia
Tablet
2K
$4.83
$0.0024
Bulk generic tablet
Oct 2025
EUGIA PHARMA SPE…
Tanzania
Tablet
8K
$25.26
$0.0033
Bulk generic tablet
Dec 2025
VEA IMPEX (I) PV…
Somalia
Tablet
3K
$11.65
$0.0035
Bulk generic tablet
Dec 2025
VEA IMPEX (I) PV…
Somalia
Tablet
3K
$11.65
$0.0035
Bulk generic tablet
Dec 2025
VEA IMPEX (I) PV…
Somalia
Tablet
3K
$11.65
$0.0035
Bulk generic tablet
Dec 2025
SUN PHARMACEUTIC…
Belgium
Tablet
39K
$178.95
$0.0045
Bulk generic tablet
Dec 2025
SRS PHARMACEUTIC…
Myanmar
Tablet
20K
$103.91
$0.0052
Bulk generic tablet
Dec 2025
H V A INTERNATIO…
Guyana
Tablet
3K
$16.95
$0.0055
Bulk generic tablet
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
Dosage form is the #1 price driver, not destination
Light cells = easy-entry markets for small suppliers
Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship letrozole, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAYLetrozole leaves India through 14+ ports. The top 5 (NASHIK-JANORI AIR, HYDERABAD ICD, MUNDRA SEA) handle 78.3% of total USD. SEA moves 27% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NASHIK-JANORI AIR handles $588K — top 14 Indian origin ports by trade value.
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
Route
Mode
Transit time
Notes
NHAVA SHEVA SEA (JNPT) → US East Coast
Sea
22–28 days
Via Suez; 2–3 transshipments typical
NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria)
Sea
18–24 days
Direct liner service available
MUMBAI AIR (SAHAR) → New York JFK
Air
3–5 days
Direct cargo; cold-chain available
MUNDRA SEA → Rotterdam
Sea
20–26 days
Via Suez; Hamburg also served
HYDERABAD AIR → London Heathrow
Air
2–4 days
Pharma-grade cargo corridor
CHENNAI SEA → Chittagong (Bangladesh)
Sea
7–12 days
Short-sea route; high frequency
RAXAUL → Birgunj (Nepal)
Road
1–2 days
Land border crossing
NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya)
Sea
14–20 days
Direct or via Colombo hub
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAYSEA dominates at 27% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$1.3M
41.6% of USD · 27.3% of ships
AIR
$1.3M
40.3% of USD · 66.3% of ships
ICD
$585K
18.1% of USD · 6.4% of ships
Fig 8.3 The dominant corridor is NASHIK-JANORI AIR → Air → Asia ($588K).
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAYNetherlands is the most concentrated destination (HHI 10000, 1 suppliers). United Kingdom is the most competitive (HHI 2998).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Netherlands (HHI 10,000) is the most concentrated — United Kingdom (HHI 2,998) is the most competitive.
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
Buyer
Country
Sole supplier
USD
Ships
Risk
THE GOVERNMENT PHARM…
Thailand
CIPLA LTD
$588K
3
CRITICAL
APL SWIFT SERVICES (…
Malta
EUGIA PHARMA SPE…
$354K
12
HIGH
JDS CO LTD
Myanmar
SUN PHARMACEUTIC…
$250K
1
HIGH
PHARMASCIENCE INC
Canada
CIPLA LTD
$210K
4
HIGH
TO COMMERCIAL BANK O…
Sri Lanka
SUN PHARMACEUTIC…
$162K
1
HIGH
SUN PHARMA PHILIPPIN…
Philippines
SUN PHARMACEUTIC…
$162K
1
HIGH
AUROLOGISTICS LLC
United States
EUGIA PHARMA SPE…
$139K
2
HIGH
HAPHARCO J.S.C BRANCH
Vietnam
SUN PHARMACEUTIC…
$134K
1
HIGH
Conclusion: 68 buyers depend on exactly one Indian supplier, representing $2.8M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
Buyer
Country
Suppliers
USD
Dominant
Resilience
EMIRATES POST GROUP
United Arab Emirates
8
$578
RUHAN IMPEX
HIGH
Conclusion: 1 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
Country
Tier
Lead
Price
Risk
Entry approach
Thailand
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
Malta
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Myanmar
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Canada
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
United Kingdom
Tier 3 (emerging)
3–5 days (air)
$0.10–$1/unit
LOW
First-mover advantage
United States
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Philippines
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Greece
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Netherlands
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
Sri Lanka
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Belgium
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Vietnam
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Mexico
Tier 3 (emerging)
3–5 days (air)
$1–$10/unit
LOW
First-mover advantage
Australia
Tier 3 (emerging)
14–28 days (sea)
$0.01–$0.10/unit
LOW
First-mover advantage
Colombia
Tier 3 (emerging)
3–5 days (air)
$0.01–$0.10/unit
LOW
First-mover advantage
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAYQuick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
ID
Action
Timing
Impact
A1
Pitch top single-source buyer in Thailand
This Q
HIGH
A2
Offer alternative to EMIRATES POST
This Q
HIGH
A3
Audit Netherlands lock-ins (HHI 10000)
This Q
MED
A5
Enter Philippines (5 suppliers)
This Q
HIGH
A6
Enter DR Congo (3 suppliers)
This Q
MED
A8
Build Malta distribution
6–12m
HIGH
A9
Bundle injection/infusion catalog for premium markets
6–12m
MED
B
FOR BUYERS
ID
Action
Timing
Impact
A4
Monitor rising exporters (CIPLA LTD)
This Q
MED
A7
Register for Thailand tenders
6–12m
HIGH
A10
Track quarterly HHI shifts across key destinations
This Q
LOW
A11
Map competitor buyer portfolios quarterly
This Q
MED
A12
Qualify second source for single-source buyers
This Q
MED
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
#
Country
Region
Suppliers
Q4 USD
Growth
Barrier
Why this is easy
1
Philippines
Asia
5
$208K
+3143.6%
LOW
Growing 3144% with only 5 competitors
2
DR Congo
Africa
3
$7K
+76010%
LOW
Growing 76010% with only 3 competitors
3
United Kingdom
Other
4
$222K
+248.8%
LOW
Growing 249% with only 4 competitors
4
Thailand
Asia
1
$588K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
5
Malta
Other
2
$354K
-76.5%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
6
Afghanistan
Asia
3
$17K
+1695.1%
LOW
Growing 1695% with only 3 competitors
7
Myanmar
Asia
4
$273K
0%
LOW
Low competition (4 suppliers), accessible market
8
Canada
Other
2
$236K
-50.3%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
9
United States
Other
2
$219K
-25.5%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
10
Greece
Other
1
$188K
-100%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
11
Netherlands
Other
1
$175K
-53.7%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
12
Sri Lanka
Asia
1
$162K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
13
Belgium
Other
1
$138K
-57.3%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
14
Vietnam
Asia
1
$134K
0%
LOW
Only 1 Indian suppliers — near-monopoly, easy second-source entry
15
Mexico
Other
2
$77K
0%
LOW
Only 2 Indian suppliers — near-monopoly, easy second-source entry
This report covers 264 2025-Q4 Letrozole shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/letrozole
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAYThis section contains every one of the 264 2025-Q4 letrozole shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian letrozole shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
264
across all regions
TOTAL USD
$3.23M
2025-Q4 FOB value
UNITS
42.8M
tablets, capsules, etc.
SUPPLIERS
68
Indian exporters
BUYERS
72
global importers
COUNTRIES
49
destinations
§10.2 Regional breakdown
Africa
$78K
2.4%
18 ctry · 54 ships
Asia
$1.41M
43.5%
13 ctry · 97 ships
Europe
$1.11M
34.4%
8 ctry · 90 ships
Americas
$579K
17.9%
9 ctry · 21 ships
Oceania
$58K
1.8%
1 ctry · 2 ships
§10.3 Key insights from the data
🌍
Africa is the largest region at $78K (2.4%), spanning 18 countries.
🏢
68 Indian suppliers shipped to 72 buyers across 49 countries — average shipment value $12K.
📄
Top 0 markets: .
🔍
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
All 70 global letrozole importers — complete list ranked by USD
KEY TAKEAWAYThis directory lists every company that imported Indian letrozole in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
#
Buyer
Country
Ships
USD
Primary supplier
Dosage forms
1
THE GOVERNMENT PHARMACEUTICAL ORGAN
Thailand
3
$588K
CIPLA LTD
Tablet
2
APL SWIFT SERVICES (MALTA) LTD
Malta
12
$354K
EUGIA PHARMA SPECIAL…
Tablet
3
JDS CO LTD
Myanmar
1
$250K
SUN PHARMACEUTICAL I…
Tablet
4
PHARMASCIENCE INC
Canada
4
$210K
CIPLA LTD
Tablet
5
TO COMMERCIAL BANK OF CEYLON
Sri Lanka
1
$162K
SUN PHARMACEUTICAL I…
Tablet
6
SUN PHARMA PHILIPPINES INC
Philippines
1
$162K
SUN PHARMACEUTICAL I…
Tablet
7
AUROLOGISTICS LLC
United States
2
$139K
EUGIA PHARMA SPECIAL…
Tablet
8
HAPHARCO J.S.C BRANCH
Vietnam
1
$134K
SUN PHARMACEUTICAL I…
Tablet
9
YUSEN LOGISTICS BENELUX BELGIUMKEET
Belgium
3
$97K
SUN PHARMACEUTICAL I…
Tablet
10
EVERSANA LIFE SCIENCES SERVICES LLC
United States
3
$80K
INTAS PHARMACEUTICAL…
Tablet
11
AUROVIDA FARMACEUTICA SA DE CV
Mexico
1
$77K
EUGIA PHARMA SPECIAL…
Tablet
12
ACCORD HEALTHCARE LTD
United Kingdom
4
$63K
INTAS PHARMACEUTICAL…
Tablet
13
BROCACEF NL:EU HUB
Netherlands
6
$59K
INTAS PHARMACEUTICAL…
Tablet
14
ACCORD HEALTHCARE FRANCE SAS
Netherlands
6
$58K
INTAS PHARMACEUTICAL…
Tablet
15
ALLOGA UK LTD
United Kingdom
3
$50K
CIPLA LTD
Tablet
16
SCIOM LTD
United Kingdom
1
$42K
SAKAR HEALTHCARE LTD
Tablet
17
YUSEN LOGISTICS BENELUX BELGIUM
Belgium
3
$41K
SUN PHARMACEUTICAL I…
Tablet
18
MOBIUS LABORATORIES LTD
United Kingdom
1
$32K
STERIL-GENE LIFE SCI…
Tablet
19
EUGIA PHARMA COLOMBIA SAS
Colombia
1
$32K
EUGIA PHARMA SPECIAL…
Tablet
20
GENERIC HEALTH.,.20 SKYLINE CRESCEN
Australia
1
$31K
CIPLA LTD
Tablet
21
ARROW PHARMACEUTICALS PTY LTD
Australia
1
$27K
CIPLA LTD
Tablet
22
BROCACEF NL : EU HUB
Netherlands
3
$19K
INTAS PHARMACEUTICAL…
Tablet
23
GENERICS & SPECIALITIES LTD
Tanzania
2
$14K
EUGIA PHARMA SPECIAL…
Tablet
24
ZYDUS NIKKHO FARMACEUTICA LTDA
Brazil
1
$14K
ZYDUS LIFESCIENCES LTD
Tablet
25
LABORATORIOS COMBIX S.L
Spain
1
$11K
ZYDUS LIFESCIENCES LTD
Tablet
26
ETEMAD MOSLEH LTD
Afghanistan
3
$11K
INTEGRATED LABORATOR…
Tablet
27
NEBULA TRADING CO LTD
Myanmar
2
$9K
SRS PHARMACEUTICALS …
Tablet
28
LEMEX PHARMACEUTICALS LTD
Mauritius
1
$6K
ADMAC LIFESCIENCES
Tablet
29
MR VONMUNA
Laos
1
$5K
KASO PHARMACEUTICALS
Tablet
30
RENATO C LOZADA
Philippines
2
$5K
MALLESHWAR SPECIALIT…
Tablet
31
DOMAKS INVESTMENT LTD
Nigeria
2
$4K
TIRTHAS INTERNATIONAL
Tablet
32
ARK OF GLO NIG LTD
Nigeria
1
$3K
ALLIAANCE BIOTECH
Tablet
33
ZAHIR HADROGULL LTD
Afghanistan
1
$3K
MANKIND PHARMA LTD
Tablet
34
GALAXY PHARMACEUTICAL LTD
Kenya
1
$3K
PRISM MEDICO AND PHA…
Tablet
35
ZYDUS HEALTHCARE PHILIPPINES INC
Philippines
1
$2K
ZYDUS LIFESCIENCES LTD
Tablet
36
EL BATRAN PHARMACEUTICAL CO.(L.T.D)
South Sudan
1
$2K
ASIAN MEDICAL
Tablet
37
SMARK FZE
United Arab Emirates
1
$2K
MEDLINE WORLD SURGIC…
Tablet
38
BROCACEF NL : LOCAL
Netherlands
1
$2K
INTAS PHARMACEUTICAL…
Tablet
39
MAOWJ ALDAWALALAV CITY VIEW, E
United Arab Emirates
1
$2K
MASCOT HEALTH SERIES…
Tablet
40
2MG INC
Philippines
2
$2K
BETA DRUGS LTD
Tablet
41
KUOL UTONG MIYEN
Sudan
1
$2K
MILTON GLOBEXO LLP
Tablet
42
SINO UNIVERSAL PHARMACEUTICALS CO
China
1
$1K
SUN PHARMACEUTICAL I…
Tablet
43
CLINIQUE "AUTEL DELIE
Togo
1
$821.16
MEDNEXT PHARMA PVT LTD
Tablet
44
EMIRATES POST GROUP
United Arab Emirates
43
$578.29
RUHAN IMPEX
Tablet
45
STE. SIMCO S.A
Kenya
1
$546.75
AURA LIFECARE PVT LTD
Tablet
46
BISTRA PHARMA LINK PVT LTD
Nepal
2
$401.40
KHANDELWAL LABORATOR…
Tablet
47
KUOL UTONG MINYAN
South Sudan
2
$303.03
BAKER & DAVIS PVT LTD
Tablet
48
GOLD TREE PHARMACEUTICALS LTD
Kenya
1
$249.17
ASPIDA LIFE SCIENCES…
Tablet
49
HAROON TIMOR ZAHIRI LTD
Afghanistan
2
$198.45
KERK
Tablet
50
MADAU KUAAC AYAI KON
Sudan
3
$134.77
AFRO LIFESCIENCE
Tablet
51
MED-CHIP PHARMACY
Zimbabwe
2
$134.46
S P PHARMA ENTERPRISES
Tablet
52
FREIGHTER MADE LOGISTICS LTD
Ghana
1
$105.72
BAKER & DAVIS PVT LTD
Tablet
53
LATOYA SHONELL GOODINGS
Guyana
1
$61.20
PHARMACO LIFESCIENCES
Tablet
54
YASSIR BRIMA
Chad
1
$60.02
BAKER & DAVIS PVT LTD
Tablet
55
K.T.Z. COMPANY LTD
Myanmar
1
$52.38
KHANDELWAL LABORATOR…
Tablet
56
NASHAAD PHARMA & SURGICAL
Somalia
2
$51.37
RAFAIS
Tablet
57
LINEHAUL EXPRESS LLC
United Arab Emirates
1
$30.23
RUHAN IMPEX
Tablet
58
EMIRATES POST COMPANY
United Arab Emirates
2
$27.43
LAWRENCE WALTER
Tablet
59
SALAMA PHARMACUTICALS LTD
Kenya
1
$25.67
M T MADON EXPORTS
Tablet
60
REGENCY EXIM TRADE LTD
Mauritius
1
$25.25
SAVA HEALTHCARE LTD
Tablet
61
TO THE DIRECTOR OF
DR Congo
1
$25.16
SCOTT EDIL PHARMACIA…
Tablet
62
AL-NOOR FOR DRUGS & MEDICAL APPLIAN
Yemen
1
$23.46
J.A. UNITED EXPORTS …
Tablet
63
NEW GPC INC
Guyana
1
$16.95
H V A INTERNATIONAL
Tablet
64
PSM PHARMACEUTICALS LTD
Kenya
1
$15.56
KHANDELWAL LABORATOR…
Tablet
65
MENNA PHARMACEUTICALS IMPORT PLC
Ethiopia
2
$12.41
BETA DRUGS LTD
Tablet
66
LUSAKA MEDICAMP LTD
Zambia
2
$3.24
MEDICOS LIFESCIENCES
Tablet
67
N&G BROTHERS INTERNATIONAL CO LTD
South Sudan
1
$1.83
BAKER & DAVIS PVT LTD
Tablet
68
DALKHAN MEDICAL SUPPLIES LTD
Saint Lucia
1
$0.344
SARA TRADING CORP
Tablet
69
STAR CONCORD PTE LTD
Singapore
1
$0.137
ALPHA-PHARMA HEALTHC…
Tablet
70
SHAKAARI CHIN (BSO)
Jamaica
1
$0.031
JEEDNYA PHARMA
Tablet
This report covers 264 2025-Q4 Letrozole shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/letrozole
Talk to our trade analyst
Need a custom letrozole report or a deeper dive into any market? Our team is ready.